These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 25196510)

  • 21. Generation and optimization of the self-administered pediatric bleeding questionnaire and its validation as a screening tool for von Willebrand disease.
    Casey LJ; Tuttle A; Grabell J; Hopman W; Moorehead PC; Blanchette VS; Wu JK; Steele M; Klaassen RJ; Silva M; Rand ML; James PD
    Pediatr Blood Cancer; 2017 Oct; 64(10):. PubMed ID: 28453185
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The ISTH Bleeding Assessment Tool and the risk of future bleeding.
    Fasulo MR; Biguzzi E; Abbattista M; Stufano F; Pagliari MT; Mancini I; Gorski MM; Cannavò A; Corgiolu M; Peyvandi F; Rosendaal FR
    J Thromb Haemost; 2018 Jan; 16(1):125-130. PubMed ID: 29064634
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prospective evaluation of the clinical utility of quantitative bleeding severity assessment in patients referred for hemostatic evaluation.
    Tosetto A; Castaman G; Plug I; Rodeghiero F; Eikenboom J
    J Thromb Haemost; 2011 Jun; 9(6):1143-8. PubMed ID: 21435168
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Variable bleeding phenotype in an Amish pedigree with von Willebrand disease.
    Gupta S; Heiman M; Duncan N; Hinckley J; Di Paola J; Shapiro AD
    Am J Hematol; 2016 Oct; 91(10):E431-5. PubMed ID: 27414491
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prospective evaluation of ISTH-BAT as a predictor of bleeding disorder in adolescents presenting with heavy menstrual bleeding in a multidisciplinary hematology clinic.
    Jain S; Zhang S; Acosta M; Malone K; Kouides P; Zia A
    J Thromb Haemost; 2020 Oct; 18(10):2542-2550. PubMed ID: 32654321
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of ISTH bleeding assessment tool to predict inherited platelet dysfunction in resource constrained settings.
    Rashid A; Moiz B; Karim F; Shaikh MS; Mansoori H; Raheem A
    Scand J Clin Lab Invest; 2016 Sep; 76(5):373-8. PubMed ID: 27215135
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bleeding Severity and Phenotype in 22q11.2 Deletion Syndrome-A Cross-Sectional Investigation.
    Patel PO; Baylis AL; Hickey SE; Stanek J; Kirschner RE; Rand ML; Kumar R
    J Pediatr; 2021 Aug; 235():220-225. PubMed ID: 33836185
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prospective evaluation of a pediatric bleeding questionnaire and the ISTH bleeding assessment tool in children and parents in routine clinical practice.
    Bidlingmaier C; Grote V; Budde U; Olivieri M; Kurnik K
    J Thromb Haemost; 2012 Jul; 10(7):1335-41. PubMed ID: 22578063
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Validation of the ISTH/SSC bleeding assessment tool for inherited platelet disorders: A communication from the Platelet Physiology SSC.
    Gresele P; Orsini S; Noris P; Falcinelli E; Alessi MC; Bury L; Borhany M; Santoro C; Glembotsky AC; Cid AR; Tosetto A; De Candia E; Fontana P; Guglielmini G; Pecci A;
    J Thromb Haemost; 2020 Mar; 18(3):732-739. PubMed ID: 31750621
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Are Iranian patients with von Willebrand disease type 2N properly differentiated from hemophilia A and do they receive appropriate treatment?
    Seidi Zadeh O; Ahmadinejad M; Amoohossein B; Homayoun S
    Blood Coagul Fibrinolysis; 2020 Sep; 31(6):382-386. PubMed ID: 32815913
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bleeding scores: are they really useful?
    O'Brien SH
    Hematology Am Soc Hematol Educ Program; 2012; 2012():152-6. PubMed ID: 23233574
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The evolution and value of bleeding assessment tools.
    Rydz N; James PD
    J Thromb Haemost; 2012 Nov; 10(11):2223-9. PubMed ID: 22974079
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bleeding Scores for the Diagnosis of von Willebrand Disease.
    Bowman ML; James PD
    Semin Thromb Hemost; 2017 Jul; 43(5):530-539. PubMed ID: 28196380
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The condensed MCMDM-1 VWD bleeding questionnaire as a predictor of bleeding disorders in women with unexplained menorrhagia.
    Azzam HA; Goneim HR; El-Saddik AM; Azmy E; Hassan M; El-Sharawy S
    Blood Coagul Fibrinolysis; 2012 Jun; 23(4):311-5. PubMed ID: 22450545
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of Pediatric Bleeding Questionnaire in Turkish Children With Von Willebrand Disease and Platelet Function Disorders.
    Belen B; Kocak U; Isik M; Keskin EY; Oner N; Sal E; Kaya Z; Yenicesu I; Gursel T
    Clin Appl Thromb Hemost; 2015 Sep; 21(6):565-9. PubMed ID: 24563246
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Determinants of bleeding phenotype in adult patients with moderate or severe von Willebrand disease.
    de Wee EM; Sanders YV; Mauser-Bunschoten EP; van der Bom JG; Degenaar-Dujardin ME; Eikenboom J; de Goede-Bolder A; Laros-van Gorkom BA; Meijer K; Hamulyák K; Nijziel MR; Fijnvandraat K; Leebeek FW;
    Thromb Haemost; 2012 Oct; 108(4):683-92. PubMed ID: 22918553
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of plasma von Willebrand factor levels in the diagnosis of type 1 von Willebrand disease: results from a multicenter European study (MCMDM-1VWD).
    Tosetto A; Rodeghiero F; Castaman G; Bernardi M; Bertoncello K; Goodeve A; Federici AB; Batlle J; Meyer D; Mazurier C; Goudemand J; Eikenboom J; Schneppenheim R; Budde U; Ingerslev J; Vorlova Z; Habart D; Holmberg L; Lethagen S; Pasi J; Hill F; Peake I
    J Thromb Haemost; 2007 Apr; 5(4):715-21. PubMed ID: 17408405
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The impact of bleeding history, von Willebrand factor and PFA-100(®) on the diagnosis of type 1 von Willebrand disease: results from the European study MCMDM-1VWD.
    Castaman G; Tosetto A; Goodeve A; Federici AB; Lethagen S; Budde U; Batlle J; Meyer D; Mazurier C; Goudemand J; Eikenboom J; Schneppenheim R; Ingerslev J; Habart D; Hill F; Peake I; Rodeghiero F
    Br J Haematol; 2010 Nov; 151(3):245-51. PubMed ID: 20738304
    [TBL] [Abstract][Full Text] [Related]  

  • 39. von Willebrand disease in a pediatric-based population--comparison of type 1 diagnostic criteria and use of the PFA-100 and a von Willebrand factor/collagen-binding assay.
    Dean JA; Blanchette VS; Carcao MD; Stain AM; Sparling CR; Siekmann J; Turecek PL; Lillicrap D; Rand ML
    Thromb Haemost; 2000 Sep; 84(3):401-9. PubMed ID: 11019962
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bleeding score in type 1 von Willebrand disease patients using the condensed MCMDM-1 vWD validated questionnaire.
    Pathare A; Al Hajri F; Al Omrani S; Al Obaidani N; Al Balushi B; Al Falahi K
    Int J Lab Hematol; 2018 Oct; 40(5):515-520. PubMed ID: 29754468
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.